NEOS Investment Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

NEOS Investment Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,774	Closed	-$400K	–	588
2024 Q1	$400K	Sell	18,774 -12,165	-39%	-$146K	0.02%	438
2023 Q4	$297K	Buy	30,939 +13,446	+77%	+$65.3K	0.03%	389
2023 Q3	$45.5K	Buy	+17,493	New	+$56.1K	0.01%	357

NEOS Investment Management's FUSN Position: Q2 2024 in Review

NEOS Investment Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 18,774 shares — an estimated $400K sold.

NEOS Investment Management first reported a position in FUSN in Q3 2023 and held it in 3 quarters. The position peaked at $400K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

NEOS Investment Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
NEOS Investment Management sold 18,774 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $400K.
NEOS Investment Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2023 and held it in 3 quarters.
NEOS Investment Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $400K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on NEOS Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.